Clinical Trials Directory

Trials / Completed

CompletedNCT05526287

Effects of Dual-Task Training in People With Multiple Sclerosis

Effects of Dual-Task Training on Balance, Gait, Dual-Task Performance, Cognitive Function, Fatigue in People With Multiple Sclerosis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Ege University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the effects of dual task training on balance, gait, dual-task performance, cognitive function, fatigue and functional mobility in people with Multiple Sclerosis(MS).

Detailed description

Eligible participants will be randomized to dual-task group or control group. Dual-task group will receive 8 weeks of dual-task training twice a week and home exercise program. Control group will receive only home exercise program for 8 weeks. Each participant will be assessed before and after the 8 weeks of treatment.

Conditions

Interventions

TypeNameDescription
OTHERDual-Task TrainingDual-task training sessions include; walking on treadmill for 10-30 minutes and half of this walking period participants will perform cognitive tasks, cognitive tasks will be repeated on tandem stance position and single leg stance position other half of the session consists of motor-motor dual task activities and gait training on firm and soft surfaces. Home exercise program includes lower extremity, core stability and balance exercises and will be performed three times a week.
OTHERHome Exercise ProgramHome exercise program includes lower extremity, core stability and balance exercises and will be performed three times a week.

Timeline

Start date
2022-11-01
Primary completion
2023-04-01
Completion
2023-08-15
First posted
2022-09-02
Last updated
2025-11-21

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05526287. Inclusion in this directory is not an endorsement.

Effects of Dual-Task Training in People With Multiple Sclerosis (NCT05526287) · Clinical Trials Directory